Inventor

SCHLOM JEFFREY

US85 patents

⚠️ This page may combine multiple inventors who share the name “SCHLOM JEFFREY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHLOM JEFFREY

US HEALTH

Peptide agonists of prostate-specific antigen and uses therefor

Variants of humanized anti carcinoma monoclonal antibody cc49

Production of a single-gene-encoded immunoglobulin

Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule

Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same

Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1

Method of enhancing a targeted immune response against tumors

Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule

Recombinant virus expressing human carcinoembryonic antigen and methods of use thereof

Monoclonal antibody (D612) having selective reactivity for gastrointestinal caricinomas and method for employing the same

Recombinant vector expressing multiple costimulatory molecules and uses thereof

Recombinant vector expressing multiple costimulatory molecules and uses thereof

Prostate specific antigen oligo-epitope peptide

Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule

HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use

Recombinant vector expressing multiple costimulatory molecules and uses thereof

Variants of humanized anti-carcinoma monoclonal antibody CC49

Monoclonal antibodies reactive with human breast cancer

Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides

Recombinant pox virus for immunization against MUC1 tumor-associated antigen

Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes

Immunogenic peptides and methods of use

Recombinant pox virus for immunization against tumor-associated antigens

Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides

Nucleic acids encoding HLA-A24 agonist epitopes of MUC1-C oncoprotein

Native and agonist CTL epitopes of the MUC1 tumor antigen

Methods of stimulating an immune response against prostate specific antigen

Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use

Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72

GLOBEIMMUNE INC

Yeast-brachyury immunotherapeutic compositions

Yeast-Brachyury immunotherapeutic compositions

Yeast-MUC1 immunotherapeutic compositions and uses thereof

Yeast-brachyury immunotherapeutic compositions

Combination immunotherapy compositions against cancer and methods

Yeast-MUC1 immunotherapeutic compositions and uses thereof

DOW CHEMICAL CO

Family of anti-carcinoembryonic antigen chimeric antibodies

Humanized anti-tag-72 monoclonal antibodies using human subgroup 4 kappa light chains

Family of high affinity, modified antibodies for cancer treatment

Family of high affinity, modified antibodies for cancer treatment

Family of high affinity, modified antibodies for cancer treatment

SCHLOM JEFFREY

Immunogenic peptides and methods of use

Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

Brachyury polypeptides and methods for use

Brachyury polypeptides and methods for use

THERION BIOLOG CORP

Generation of immune responses to prostate-specific antigen (PSA)

Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof

Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof

HODGE JAMES

Combination immunotherapy compositions against cancer and methods

THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES

HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use